The Associated Press -- NEW YORK -- Fourth-quarter profit plunged for Bristol-Myers Squibb Co. because of a huge gain a year ago, but the drugmaker saw its sales rise slightly and met Wall Street’s earnings-per-share expectations.
The Associated Press -- NEW YORK -- Fourth-quarter profit plunged for Bristol-Myers Squibb Co. because of a huge gain a year ago, but the drugmaker saw its sales rise slightly and met Wall Street’s earnings-per-share expectations.
